Advertise   Subscribe Contact Yemen Post
 
About Us   Our Mission Terms & Services
Yemen Post Newspaper Logo  
Editor Picture The first of a hundred steps is now complete. We salute those who helped the NDC become the road map for the future Yemen. Strides of success were made, but the real test awaits us all. Will the government deliver and turn ink on paper into reality?  
Hakim Almasmari  
 Publisher & Editor in Chief   
  Email the Editor
Advanced Search
HOME EDITORIAL LOCAL INTERVIEW REPORT POLITICS BUSINESS HEALTH YEMEN IN THE NEWS MIDDLE EAST INTERNATIONAL ARCHIVE
LATEST UPDATES Hadi vows strict measures to punish those attempting to destabilize Yemen :: CBY Governor: Fiscal situation stable after reforms in Yemen :: G10 Ambassadors in Yemen Demand Houthi to Respect law :: Yemen forces on high alert as militants rally on outskirts of capital :: For fifth successive year, China ranks as first trade partner with Yemen in 2013 :: Yemen President intensifies meeting with aides, formes new committee on Saada :: Britain first EU country to advise nationals to leave Yemen :: MP Hamid Al-Ahmer, Benomar discuss political developments in Yemen :: IFJ calls for urgent measures to protect Yemeni Journalists :: National Authority for Monitoring the implementation of NDC Outcomes Working groups Resume Work ::
BREAKING NEWS
z
HEALTH
Last updated: 11:16:45 PM GMT(+03) Sunday, 16, December, 2012
 
 

Doing good business for better health in Yemen

 
*
 Yemen Post Staff

By Omar Mulhi

Country Manager for GlaxoSmithKline- Yemen

 

 

The drive to ensure access to medicine across Yemen is a vital priority in which private sector companies, governments, NGOs, international agencies and academic institutions all have a vital role to play. True, pharmaceutical companies have not always been seen as altruistic leaders in this field, but in recent years our industry has been playing an increasingly progressive part. Today, we are seen as part of the solution.
Last week, the annual Access to Medicine Index was published. This ranking, published by the Access to Medicine Foundation, an independent, not-for-profit organisation, rates pharmaceutical companies according to their efforts to bring essential medicines to people in low-income countries.
I am pleased that, for the third consecutive time, GlaxoSmithKline (GSK) is ranked highest. This ranking is a public recognition that validates our objective: to improve people’s health and well-being, regardless of where they live in the world or their ability to pay. In developing countries, we give equal focus to building a sustainable business and on working with partners to improve healthcare in that country.
Previously the healthcare industry reached only the more affluent end of the population, but thanks to economic growth and partnerships in these countries, it has led to improvements in the healthcare infrastructure, training and supply, which means we are now able to expand our reach. Further investments and partnerships are required to ensure life-saving medicines reach societies in need, but it is entirely possible for private companies with a social conscience to achieve commercial success and meet the healthcare needs of the people.
GSK’s number-one ranking in the Index further acknowledges our four -part strategic approach in low-income countries, that is:
1) Having a unique business model, that incentivises managers on volume targets to drive access rather than just profit;
2) That caps the price of our patented medicines at no more than 25 per cent of the price in the UK;
3) That re-invests 20 per cent of all profits back into improving Yemen’s healthcare infrastructure; and
4) Is done so in partnership with governments, NGOs and the private sector.
GSK’s business model focuses on selling a higher volume of medicines at lower prices. This allows us to reach more people, and save more lives. This is not easy work, but it is critically important to building a stronger, healthier future for everyone in Yemen.
We are committed to re-investing 20 per cent of profits generated in the world’s least developed countries back into community programmes. These projects are designed to strengthen the local healthcare infrastructure, and provide training for community health workers. Today, we have begun projects in all least developed countries where we make a profit, including Yemen.
GSK is taking a different approach to meeting the challenges in these countries, working in partnership with others and aligning the healthcare needs of people in developing countries with the commercial success that will ensure sustained investment. Our partnerships are central to the success of these endeavours – a sign of the new paradigm for our industry. With the right commitment and support from governments and NGOs and the involvement of the private sector, the potential impact is staggering – to make quality medicines and vaccines available to everyone and not just the privileged few. This will achieve quantum gains in Yemen’s health and development to provide a better, healthier and brighter future for people, communities and societies. That, surely, is a goal worth pursuing.
 

About the author
Omar Mulhi worked with GSK between 1995 and 2010. He started his career as a medical representative and was promoted to a number of progressively senior positions in the organisation with the last role being Second Line Sales Manager in 2010. Omar took the role of GSK country manager effective from June 2012 looking after both institutional and
private business in Yemen.

 

 

 

 


*
Source: Yemen Post Newspaper
 
 
MORE HEALTH
 
KSA to help Yemen defeat Malaria to protect its people
MERS-related death prompt fears of outbreak in Yemen
Yemen health officials move to fight Schistosomiasis
Self sustaining cardiac surgery program established in USTH
Social Health Insurance in Yemen: The Unpaved Road
Female empowerment through voluntary work in the health sector!
Yemen AIDS program to tackle stigmatization
More Support to Yemeni Patients and Health Sector; GSK Launches Access to Medicine Program
Cases of AIDS in Yemen on the rise
Yemen battles schistosomiasis: national health campaign
 
 
Comments
 
Leave a Comment
Comment will be published once it has been approved by our moderators.
Name:
Title:
Comment:

TERMS AND CONDITIONS
Yemen Post may edit comments for length and clarity but will not change the tone of the message. Comments will only be accepted if all fields (including name) are filled correctly and the message isn't abusive, defamatory or offensive. All comments sent may be forwarded for use in the Yemen Post newspaper.
Article Tools
Email this Article Email this article
Print Friendly Version Print
Email this Article Email the Editor
 
Most popular
 For fifth successive year, China ranks as first trade partner with Yemen in 2013
 Yemen President intensifies meeting with aides, formes new committee on Saada
 Britain first EU country to advise nationals to leave Yemen
 Hadi vows strict measures to punish those attempting to destabilize Yemen
 Analysts say Houthi rebels seek power under change slogans
 CBY Governor: Fiscal situation stable after reforms in Yemen
 
Services
  Letters to the Editor
  Dear President
  Advertise
  Subscribe
  Submit Your Articles
  Classified
  Readers' Letters
 

 
Quick poll
Do you think President Hadi is building the base to rule Yemen for many years?

VOTE  OR SEE POLL RESULTS
 

   
   
   
© Yemen Post. All Rights Reserved 2007- 2014    

 Designed and developed by
  HyperLink